ABSCIENCES (EPA:AB) | Finanzwire

Basculer en Français

10494	Companies
221249	Keywords
150457	Articles
117008	Press releases

Home
Companies
ABSCIENCES

BRIEF

published on 08/04/2025 at 08:03, 9 months 30 days ago

AB Science Completes EUR 2.55 Million Private Placement

Private Placement Shareholders Clinical Development AB Science EUR 2.55 Million
PRESS RELEASE

published on 08/04/2025 at 07:58, 9 months 30 days ago

AB Science announces the successful completion of a 2.55 million euros private placement
AB Science successfully completes EUR 2.55 million private placement to fund clinical development. New shares issued with warrants attached

Private Placement Shareholders Clinical Development AB Science EUR 2.55 Million
BRIEF

published on 07/30/2025 at 07:50, 10 months 4 days ago

AB Science Advances in AML Study With New European Approvals

Regulatory Approval Market Potential AB8939 Venetoclax AML Study
PRESS RELEASE

published on 07/30/2025 at 07:45, 10 months 4 days ago

AB Science receives regulatory approval from European countries to initiate third stage of Phase I/II study combining its molecule AB8939 with venetoclax for the treatment of AML
AB Science receives regulatory approval from European countries to initiate third stage of Phase I/II study combining AB8939 with venetoclax for treatment of acute myeloid leukemia

Regulatory Approval AB Science AB8939 Venetoclax Phase I/II Study
BRIEF

published on 07/24/2025 at 08:01, 10 months 10 days ago

AB Science Gains Approval for Phase 3 ALS Masitinib Study Across Europe

Phase 3 Trial ALS AB Science Masitinib European Approval
PRESS RELEASE

published on 07/24/2025 at 07:56, 10 months 10 days ago

AB Science has received approval from several European countries to initiate the confirmatory phase 3 study of masitinib in ALS
AB Science receives approval from European countries to initiate Phase 3 study of masitinib in ALS following protocol validation by EMA and FDA

Phase 3 Study ALS AB Science Masitinib EMA
BRIEF

published on 07/08/2025 at 08:06, 10 months 26 days ago

AB Science Completes EUR 1.925 Million Private Placement

Private Placement Share Issuance Biotech Funding AB Science AB8939 Program
PRESS RELEASE

published on 07/08/2025 at 08:01, 10 months 26 days ago

AB Science announces the successful completion of a EUR 1.925 million private placement
AB Science successfully completes EUR 1.925 million private placement to finance ongoing activities and focus on AB8939 program development. New shares to be admitted to trading on Euronext Paris

Private Placement Euronext Paris AB Science AB8939 Program EUR 1.925 Million
BRIEF

published on 07/04/2025 at 08:06, 10 months 30 days ago

AB Science: Green light for phase 3 study of masitinib in prostate cancer

Phase 3 AB Science Masitinib Prostate Cancer FDA And EMA
BRIEF

published on 07/01/2025 at 10:13, 11 months 1 day ago

Results of the AB Science General Meeting

Share Capital Voting Rights Resolutions General Assembly AB Science

Accesswire

Published on 06/03/2026 at 04:58, 3 hours 41 minutes ago

Snipp Interactive Reports Q1 2026 Financial Results; Bookings Backlog Reaches Record $20.6 Million; Announces Conference Call on Wednesday, June 3, 2026
Published on 06/03/2026 at 00:00, 8 hours 39 minutes ago

Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program
Published on 06/02/2026 at 22:30, 10 hours 9 minutes ago

INEO Announces Effective Date of Share Consolidation
Published on 06/02/2026 at 22:00, 10 hours 39 minutes ago

NYMOX Provides Current Update
Published on 06/02/2026 at 19:45, 12 hours 54 minutes ago

Announces Plans to Repurchase Common Shares

View all ACCESSWIRE

EQS Group

Published on 06/03/2026 at 08:00, 39 minutes ago

Aquis Stock Exchange: Application for Admission Announcement
Published on 06/03/2026 at 07:35, 1 hour 3 minutes ago

Factorial Raises $150M Series D, Reaches $2.5 Billion Valuation to Become One of the Most Valuable AI Scale-Ups in Europe
Published on 06/03/2026 at 07:30, 1 hour 9 minutes ago

voestalpine AG: voestalpine increases earnings despite a volatile environment in the 2025/26 business year
Published on 06/03/2026 at 07:30, 1 hour 9 minutes ago

Deutsche Rohstoff AG: 2026 development on track– first pad delivers strong initial production
Published on 06/03/2026 at 07:05, 1 hour 33 minutes ago

National Bank of Georgia Launches Modernized RTGS Payment System with Montran

Les Echos

Published on 06/02/2026 at 18:03, 14 hours 35 minutes ago

Total number of voting rights and shares making up the share capital at May 31, 2026
Published on 06/02/2026 at 17:42, 14 hours 57 minutes ago

Aéroports de Paris SA - Shares and voting rights as of 31 May 2026
Published on 06/02/2026 at 17:40, 14 hours 59 minutes ago

Campus AI enters the implementation phase: Eiffage selected for deployment of shared infrastructure on the Fouju Campus in a deal worth over €120 million
Published on 06/02/2026 at 08:00, 1 day ago

EURAZEO’S PRIVATE DEBT FUND CLOSES AT RECORD €3.9 BILLION, EXCEEDING ITS INITIAL TARGET
Published on 06/02/2026 at 07:30, 1 day 1 hour ago

OPmobility strengthens its U.S. footprint with a new state-of-the-art plant in the Midwest

View all LES ECHOS COMFI WIRE